The multitude of factors implicated in anemia in critical illness includes decreased production of erythropoietin (EPO), inadequate EPO-induced bone marrow response, and diminished red cell survival, as well as treatment-associated traumatic blood loss (44). This evidence concerns the gene EPO and anemia.